ICU Medical, Inc. (ICUI)

NASDAQ: ICUI · Real-Time Price · USD

160.89

-6.69 (-3.99%)

At close: Sep 8, 2026, 4:00 PM EDT

160.79

-6.79 (-4.05%)

Pre-market: Sep 9, 2026, 6:53 AM EDT

ICU Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	4,023	3,522	3,799	2,408	3,777	5,041
Market Cap Growth	31.33%	-7.30%	57.79%	-36.25%	-25.08%	12.01%
Enterprise Value	5,008	4,601	5,134	3,892	5,241	4,549
Last Close Price	160.89	142.67	155.17	99.74	157.48	237.34

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	133.66	4811.54	-	-	-	48.88
Forward PE	52.24	178.72	33.92	33.92	33.92	47.09
PS Ratio	1.86	1.58	1.60	1.07	1.66	3.83
PB Ratio	1.87	1.66	1.93	1.13	1.81	3.12
P/TBV Ratio	40.31	-	-	-	-	3.64
P/FCF Ratio	26.33	38.37	30.48	29.25	-	25.33
P/OCF Ratio	17.02	19.58	18.62	14.49	-	18.84
PEG Ratio	4.75	16.25	31.81	31.81	3.08	4.28

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.32	2.06	2.15	1.72	2.30	3.46
EV/EBITDA Ratio	15.36	14.84	16.20	14.07	22.63	19.68
EV/EBIT Ratio	40.11	42.08	52.71	81.36	-	32.17
EV/FCF Ratio	32.77	50.12	41.19	47.29	-	22.86

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.60	0.64	0.84	0.80	0.83	0.03
Debt / EBITDA Ratio	3.76	4.12	4.85	5.67	6.84	0.19
Debt / FCF Ratio	8.42	14.74	13.18	20.71	-	0.24
Net Debt / Equity Ratio	0.46	0.49	0.67	0.67	0.71	-0.32
Net Debt / EBITDA Ratio	3.02	3.36	4.18	5.15	6.44	-2.26
Net Debt / FCF Ratio	6.44	11.34	10.61	17.32	-9.79	-2.62
Asset Turnover	0.54	0.54	0.56	0.51	0.71	0.72
Inventory Turnover	2.18	2.35	2.41	2.16	3.21	2.73
Quick Ratio	1.00	0.99	0.90	0.92	0.95	3.38
Current Ratio	2.43	2.39	2.59	2.54	2.50	5.13
Return on Equity (ROE)	1.41%	0.04%	-5.76%	-1.41%	-4.01%	6.62%
Return on Assets (ROA)	1.93%	1.66%	1.42%	0.67%	-0.07%	4.85%
Return on Invested Capital (ROIC)	3.96%	0.78%	2.85%	1.34%	-0.15%	10.58%
Return on Capital Employed (ROCE)	3.60%	3.10%	2.70%	1.20%	-0.10%	8.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.75%	0.02%	-3.10%	-1.23%	-1.97%	2.05%
FCF Yield	3.80%	2.61%	3.28%	3.42%	-4.04%	3.95%
Buyback Yield / Dilution	-2.28%	-2.12%	-1.23%	-0.93%	-9.58%	-0.88%

SEC Filings: 10-K · 10-Q